Day One Biopharmaceuticals Inc (DAWN)
14.79
-1.18
(-7.39%)
USD |
NASDAQ |
May 21, 16:00
14.81
+0.02
(+0.14%)
After-Hours: 20:00
Day One Biopharmaceuticals Total Liabilities (Quarterly): 29.84M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 29.84M |
| December 31, 2023 | 29.51M |
| September 30, 2023 | 24.55M |
| June 30, 2023 | 24.70M |
| March 31, 2023 | 23.15M |
| December 31, 2022 | 17.02M |
| September 30, 2022 | 18.78M |
| Date | Value |
|---|---|
| June 30, 2022 | 13.42M |
| March 31, 2022 | 8.176M |
| December 31, 2021 | 8.673M |
| September 30, 2021 | 6.111M |
| June 30, 2021 | 4.774M |
| March 31, 2021 | 224.95M |
| December 31, 2020 | 94.16M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.774M
Minimum
Jun 2021
224.95M
Maximum
Mar 2021
37.70M
Average
20.97M
Median
Total Liabilities (Quarterly) Benchmarks
| Revolution Medicines Inc | 182.90M |
| Zentalis Pharmaceuticals Inc | 98.71M |
| Perspective Therapeutics Inc | 48.40M |
| Electromed Inc | 6.357M |
| Xtant Medical Holdings Inc | 46.25M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 326.64M |
| Shareholders Equity (Quarterly) | 296.81M |